|Bid||78.21 x 800|
|Ask||89.97 x 800|
|Day's Range||79.94 - 81.29|
|52 Week Range||69.36 - 94.88|
|Beta (3Y Monthly)||1.43|
|PE Ratio (TTM)||18.77|
|Forward Dividend & Yield||1.60 (2.14%)|
|1y Target Est||N/A|
Steve Collis has been the CEO of AmerisourceBergen Corporation (NYSE:ABC) since 2011. This report will, first, examine...
Navient was one of 15 local companies to make Fortune magazine’s list of the highest-grossing U.S. public companies and the only new entrant from this region.
The pharmaceutical services giant sports a stellar growth record, yet fell out of favor since hitting an all-time peak of $120.70 back in 2015. AmerisourceBergen has a fine balance sheet, is more stable than average and scores in the top 5% of all 1,700 stocks covered in Value Line's main research universe in terms of earnings predictability. Since 2011, AmerisourceBergen averaged about a 15.8x P/E, accompanied by around 1.48% in current yield.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of AmerisourceBergen Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Founded in 1901, Walgreens Boots Alliance WBA is the leading pharmacy retailer, leveraging its scale to provide convenience. The company generates nearly $140 billion in revenue and dispenses over 1 billion prescriptions annually, representing one fourth of the drug market. Scale remains critical in an increasingly competitive market that has witnessed some rationalization of subscale peers.
Raymond James analyst John Ransom this week named two potential targets for Walgreens Boots Alliance (Nasdaq: WBA) – LabCorp and drug wholesaler AmerisourceBergen (NYSE: ABC).
AmerisourceBergen (ABC) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
peaked back in October and sold off with the broad market into late December. In the daily bar chart of ABC, below, we can see that prices are testing a declining or bearish 50-day moving average line and are clearly below the bearish 200-day moving average line. The daily On-Balance-Volume (OBV) line has been rising from late December and suggests that buyers of ABC have been more aggressive -- unfortunately prices have been mostly weak since February.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AmerisourceBergen Corp NYSE:ABCView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for ABC with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ABC. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $4.54 billion over the last one-month into ETFs that hold ABC are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. ABC credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
The big pharmaceutical distributor missed Wall Street's revenue estimate but delivered a strong earnings beat in Q2.
AmerisourceBergen's (ABC) Q2 earnings gain from solid segmental performance and higher adjusted operating income growth. But contraction in adjusted gross and operating margins remains a dampener.
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.65% and -0.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
The Chesterbrook, Pennsylvania-based company said it had profit of 13 cents per share. Earnings, adjusted for one-time gains and costs, were $2.11 per share. The results surpassed Wall Street expectations. ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The simplest way to benefit from a rising market is to buy an index fund. While individual stock...
Better-than-expected performance at Pharmaceutical Distribution and World Courier and higher revenues might aid AmerisourceBergen (ABC) in Q2 earnings. However, stiff competition might be a dampener.
AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Today we're going to take a look at the well-established AmerisourceBergen Corporation (NYSE:ABC). The company's stock saw significant share price movement during recent months on the NYSE, risi...